Our growing elderly population… a better vision for the future?
By the mid 2030s the number of people aged 85 and over is projected to double to reach 3.2 million, while more than 10 million people alive today will live to be 100. This demographic shift has significantly increased the prevalence of age-related diseases of the eye, especially those requiring treatment to the back of the eye such as age-related macular degeneration, diabetic retinopathy, and glaucoma. However, a number of physiological barriers in the eye and inefficient drug delivery systems prevent the effective treatment of these conditions… often resulting in blindness.
Dr Eileen McBride
Dr Eileen McBride is a post-doctoral research fellow in drug delivery at the Strathclyde Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde in Glasgow. In her presentation at the Institute of Nanotechnology’s forthcoming conference Advanced Technologies for an Ageing Population, Dr McBride will explain how these serious eye diseases affect the elderly population and what the challenges associated with their treatment are. She will review the current approaches to delivering drugs and the pitfalls associated with them, and will explore the application of advanced technologies, including MEMS delivery devices, asking the question “Can micro become nano in this space and is it appropriate?”
The Institute of Nanotechnology puts significant effort into ensuring that the information provided on its news pages is accurate and up-to-date. However, we cannot guarantee absolute accuracy. Consequently, the Institute of Nanotechnology disclaims any and all responsibility for inaccuracy, omission or any kind of deficiency in relation to the news items and articles hosted herein.
- 22 July 2014Supporting Recommendations for Future Topics in Horizon 2020
- 17 June 20142014 edition of European NanoSafety Cluster Compendium now online
- 14 May 2014Gold nanoparticles for cancer treatment
- 22 April 2014Irish Materials Research Centre (AMBER) in World First Graphene Innovation
- 15 April 2014Targeting cancer with a triple threat
- View All